Amy Allen Hinson and Micheal Binns wrote an article in Industry Today analyzing a recent U.S. Supreme Court patent ruling.
"The Supreme Court has spoken on an issue that has been unclear for over a decade, but directly impacts the business strategy of manufacturers, drug makers, and other industrial companies," Amy and Micheal wrote. "In Helsinn Healthcare v. Teva Pharmaceuticals USA, the nation’s highest court has settled the question of whether companies can still get patent rights after 'secret sales' of their inventive product."
The court answered that question with a clear "no," and you can read Amy and Micheal's breakdown here. Industry Today serves an audience of C-suite executives, decision-makers, and other professionals throughout manufacturing and industry.